Corticosteroid Clinical Trial
Official title:
Data Collection of Therapeutic Compliance in Patients Receiving Corneal Graft Using a Collection Box for Corticosteroid Eye Drops
Following corneal graft, local steroids with a gradually decreasing dose for 12 months are prescribed to reduce the graft rejection risk (maximum incidence of 20% for the first 12 months). The validated KaliJAR® device is a box for single-dose eye drops collection. This innovative tool will make it possible to objectify the compliance of patients with a corneal graft. Unlike the field of glaucoma, no specific compliance data are available for corneal grafts, although it is important because graft rejection is the most important cause of corneal graft failure.
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT05160441 -
Comparing Platelet Rich Plasma and Corticosteroid for Military & Civilian Patients With Glenohumeral Osteoarthritis
|
Phase 3 | |
| Recruiting |
NCT03365141 -
Efficacy of Intralesional Triamcinolone Injection in the Treatment of Vitiligo
|
N/A | |
| Recruiting |
NCT05160506 -
Corticosteroids to Treat Pancreatitis
|
Phase 2 | |
| Not yet recruiting |
NCT05059873 -
Treatment Efficacy of Systemic Corticosteroids in AECOPD Patients With Higher Blood Eosinophil Levels
|
Phase 4 | |
| Not yet recruiting |
NCT05750797 -
The Nationwide Real-world Status of Oral Corticosteroid Use in Patients With Asthma
|
||
| Withdrawn |
NCT05133635 -
High-Dose Corticosteroid or Tocilizumab for Clinical Worsening of COVID-19
|
Phase 4 | |
| Recruiting |
NCT05230667 -
Comparison of the Effect of Combined Glenohumeral Joint and Subdeltoid Bursa Injection With Platelet-rich Plasma (PRP), Corticosteroid, and Normal Saline in Addition to Physical Therapy for Treatment of Frozen Shoulder
|
N/A | |
| Not yet recruiting |
NCT05742061 -
Intra-articular Platelet Rich Plasma vs Corticosteroid in Treatment of Knee Osteoarthritis Patients
|
Early Phase 1 |